AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

CVE:NXGNexgenRx Stock Price, Forecast & News

C$0.18
0.00 (0.00 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.18
Now: C$0.18
C$0.18
50-Day Range
C$0.15
MA: C$0.17
C$0.20
52-Week Range
C$0.15
Now: C$0.18
C$0.33
Volume94,140 shs
Average Volume31,245 shs
Market CapitalizationC$12.24 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; and direct deposit services. In addition, it offers ancillary services. NexgenRx Inc. was founded in 2003 and is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.04 out of 5 stars


Industry, Sector and Symbol

Industry Health Care Plans
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-416-6953393

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$10.03 million
Cash FlowC$0.01 per share
Book ValueC$0.03 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$12.24 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NXG News and Ratings via Email

Sign-up to receive the latest news and ratings for NXG and its competitors with MarketBeat's FREE daily newsletter.

NexgenRx (CVE:NXG) Frequently Asked Questions

How has NexgenRx's stock been impacted by COVID-19 (Coronavirus)?

NexgenRx's stock was trading at C$0.18 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NXG shares have decreased by 2.8% and is now trading at C$0.18. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of NexgenRx?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NexgenRx in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for NexgenRx.

What price target have analysts set for NXG?

1 equities research analysts have issued 12 month target prices for NexgenRx's stock. Their forecasts range from C$4.00 to C$4.00. On average, they anticipate NexgenRx's share price to reach C$4.00 in the next year. This suggests a possible upside of 2,185.7% from the stock's current price. View analysts' price targets for NexgenRx.

Has NexgenRx been receiving favorable news coverage?

News headlines about NXG stock have trended very positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. NexgenRx earned a news impact score of 4.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an effect on the company's share price in the next several days. View the latest news aboutNexgenRx.

Who are some of NexgenRx's key competitors?

What other stocks do shareholders of NexgenRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NexgenRx investors own include WestJet Airlines (WJA) and Hydro One (H).

Who are NexgenRx's key executives?

NexgenRx's management team includes the following people:
  • Mr. Ronald C. Loucks, Founder, CEO, Pres & Director (Age 69)
  • Mr. Kelly Elher, Chief Financial Officer
  • Ms. Liliana Martino, National VP of Sales
  • Mr. Andrew Munroe, Director of Operations
  • Mr. Hugh C. Hart, VP of Sales & Account Management

What is NexgenRx's stock symbol?

NexgenRx trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NXG."

How do I buy shares of NexgenRx?

Shares of NXG and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is NexgenRx's stock price today?

One share of NXG stock can currently be purchased for approximately C$0.18.

How big of a company is NexgenRx?

NexgenRx has a market capitalization of C$12.24 million and generates C$10.03 million in revenue each year.

What is NexgenRx's official website?

The official website for NexgenRx is www.nexgenrx.com.

How can I contact NexgenRx?

NexgenRx's mailing address is 185 the West Mall Suite 600, ETOBICOKE, ON M9C 5L5, Canada. The company can be reached via phone at +1-416-6953393.

This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.